Precision BioSciences develops gene editing treatments for genetic and infectious diseases using its ARCUS platform. It last closed at $7.05 on Nov 17, down 3.16% on the day.
DTIL · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 4% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 45). The nearest support is the 50 day average at $7.01, and the nearest resistance the Pivot at $7.12.
Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 10.7%/day
Key levels
$11.2952 week high+60.1%
$7.8020 day average+10.6%
$7.43100 day average+5.4%
$7.37Pivot R1+4.5%
$7.31Swing high (Sep 22)+3.7%
$7.12Pivot+1.0%
$7.05Last close
$7.0150 day average−0.6%
$6.81Pivot S1−3.4%
$6.80200 day average−3.5%
$6.70Swing low (Jul 29)−5.0%
$3.5352 week low−49.9%
Indicators
RSI (14)
44.71
Middle of its range
Neutral
MACD
0.31
Below its signal line
Bearish
Stochastic
16.0
Near the bottom of its range
Oversold
ADX (14)
23.2
Weak trend
Williams %R
-91.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-44.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.1%
Change over 10 sessions
Bullish
ATR (14)
$0.75
Typical daily range, 10.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 19.8%/day
Key levels
$11.2952 week high+60.1%
$7.8020 day average+10.6%
$7.43100 day average+5.4%
$7.37Pivot R1+4.5%
$7.31Swing high (Sep 22)+3.7%
$7.12Pivot+1.0%
$7.05Last close
$7.0150 day average−0.6%
$6.81Pivot S1−3.4%
$6.80200 day average−3.5%
$6.70Swing low (Jul 29)−5.0%
$3.5352 week low−49.9%
Indicators
RSI (14)
49.70
Middle of its range
Neutral
MACD
0.24
Above its signal line
Bullish
Stochastic
48.2
Middle of its range
Neutral
ADX (14)
35.6
Trending up
Williams %R
-76.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-23.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.7%
Change over 10 sessions
Bearish
ATR (14)
$1.39
Typical daily range, 19.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Below
What happened before, for DTIL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how DTIL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow DTIL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How DTIL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DTIL is in one of them and how their past DTIL trades turned out.
Precision BioSciences is a gene editing company based in Durham, North Carolina. It uses its ARCUS platform, a gene editing tool built on a single protein, to develop treatments for genetic and infectious diseases. Its lead programs target chronic hepatitis B and Duchenne muscular dystrophy, and it also partners with iECURE on a treatment for ornithine transcarbamylase deficiency. The company's work is aimed at patients with these serious conditions.